Skip to main content
Top

Clinical and Translational Oncology

Issue 6/2018

Content (17 Articles)

Review Article

Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223

A. Rodriguez-Vida, M. D. Torregrosa, Á. Pinto, M. Á. Climent, D. Olmos, J. Carles

Research Article

Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study

Q. Li, H. Li, H. Jiang, Y. Feng, Y. Cui, Y. Wang, Y. Ji, Y. Yu, W. Li, C. Xu, S. Yu, R. Zhuang, T. Liu

Research Article

MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer

S. Gao, H. Liu, S. Hou, L. Wu, Z. Yang, J. Shen, L. Zhou, S.-S. Zheng, B. Jiang

Research Article

Aggressive intrahepatic therapies for synchronous hepatocellular carcinoma with pulmonary metastasis

Z. Hu, P. Huang, Z. Zhou, W. Li, J. Xu, K. Xu, J. Wang, H. Zhang

Research Article

Prognostic value of change in anti-thyroglobulin antibodies after thyroidectomy in patients with papillary thyroid carcinoma

A. Ernaga-Lorea, M. C. Hernández-Morhain, E. Anda-Apiñániz, J. J. Pineda-Arribas, I. Migueliz-Bermejo, N. Eguílaz-Esparza, A. Irigaray-Echarri

Research Article

Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain

E. Ciruelos, M. Vidal, E. Martínez de Dueñas, N. Martínez-Jáñez, Y. Fernández, J. A. García-Sáenz, L. Murillo, F. Carabantes, A. Beliera, R. Fonseca, J. Gavilá

Research Article

Cost-effectiveness analysis of sensitive relapsed small-cell lung cancer based on JCOG0605 trial

K. Zhou, F. Wen, P. Zhang, J. Zhou, H. Zheng, L. Sun, Q. Li

Research Article

LOC285629 regulates cell proliferation and motility in colorectal cancer cells

S. N. Nasir, N. Abu, N. S. Ab Mutalib, M. Ishak, I. Sagap, L. Mazlan, I. M. Rose, R. Jamal

Research Article

Determining personalized treatment by gene expression profiling in metastatic breast carcinoma patients: a pilot study

M. Sureda, J. Rebollo, E. Mª. Martínez-Navarro, F. J. Fernández-Morejón, J. Farré, V. Muñoz, P. Bretcha-Boix, M. Duarte, R. G. Manzano, A. Crespo, M. del Carmen Redal, B. Valenzuela, A. Brugarolas

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine